CALL FOR PROPOSALS
APS Disease(s)/Medical Topic(s) of the Year Initiative (NEW!)
Submissions Due June 22, 2022
APS is excited to launch a new “Disease(s)/Medical Topic(s) of the Year Initiative.
We are now seeking proposals! If you are interested in being involved with a Disease/Medical Topic of the Year and have ideas, we want to hear from you!
The proximal objectives of the Disease/Medical Topic of the Year initiative are as follows:
- Obtain the latest medical update on the selected disease or medical topic from our medical counterparts.
- In parallel, obtain the latest information regarding psychosocial risk factors and biobehavioral interventions from APS members and biopsychosocial scientists from other organizations.
- Identify synergies between the biomedical and biopsychosocial perspectives that can advance research or clinical interventions—the more specific to the disorder and the relevant biomedical and/or biopsychosocial mechanisms, the better.
- Hold a 4-5 hour virtual meeting in the fall of 2022.
- Submit a summary manuscript to Psychosomatic Medicine in Spring of 2023.
- To the extent possible, collaborate with an Editor or Associate Editor of a relevant medical journal and explore publication of guidelines for practitioners for the chosen disorder.
- Partner with members from other professional organizations for presentations at the meeting and writing/endorsing the final manuscript.
If you or your collaborators are interested in this new Disease/Medical Topic of the Year Initiative, please prepare answers the following questions and enter them in this form. The deadline for submissions is June 22.
- What is the proposed disease or medically-relevant topic/theme?
- Who is the principal organizer (Name, degree, affiliation, email and mobile number). The principal organizer must be a member of APS.
- If possible, list the names, affiliations and email addresses of other planned or potential presenters and whether or not they are APS members.
- In one paragraph please summarize the rationale for this topic, why it is timely and the types of advances (biomedical and/or biopsychosocial) that would likely be presented
- Are you willing to present at a fall virtual meeting for 4-5 hours at an agreed upon day/time?
- Completing a manuscript summarizing the conclusions of the meeting is required by spring 2023. Will meeting this deadline be feasible?
- Disseminating these results is critical to address identified gaps and seize clinical and research opportunities. Partnering with other organizations in medicine, behavioral medicine, and psychology is a major goal. With which other organizations will you collaborate? Organizational endorsements and active participation would be very welcome.
For additional information on this program click here.
The Oversight Committee consists of the following members:
Allison Gaffey, Loretta Hsueh, Richard Lane, Michael Mangold, Matt Muldoon and John Ruiz.